Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

It’s Time to Hedge as VIX Nears 2019 ‘Floor’, Macro Risk Says

Published 20/11/2019, 20:48
Updated 20/11/2019, 23:11
It’s Time to Hedge as VIX Nears 2019 ‘Floor’, Macro Risk Says

(Bloomberg) -- The rally in U.S. stocks may have waned, but equities are still near record highs amid subdued volatility. For some strategists, that may be the perfect time to seek protection.

Macro Risk Advisors suggests a trade that involves selling a put option on the Cboe Volatility Index with a strike of 12, while buying a 20 call and selling a 22 call. Derivatives strategist Maxwell Grinacoff wrote in a note Tuesday that he backtested the strategy, both unconditionally and when VIX was below 13, and found it has performed relatively well since the beginning of 2018.

“We believe VIX has neared its theoretical floor for the year,” Grinacoff wrote. In addition, historical correlation trends in the S&P 500 around earnings season imply “a higher level of realized volatility going forward.”

These calls for vigilance are already bearing fruit. The VIX rose to its highest level in nearly a month on Wednesday after a report that the U.S. and China are unlikely to reach a trade deal this year.

Read: ‘Giant Risk Event’ Makes Hedging a Good Bet in 2020, TD Says

Europe long volatility looks relatively attractive with the VStoxx Index so low, UBS Group AG strategist Stuart Kaiser wrote in a note Nov. 17. The European volatility gauge fell to 11.54 on Nov. 15, compared with this year’s mean of about 15.3. Kaiser also likes the iShares Russell 2000 ETF as a preferred medium-term growth-sensitive hedge.

Put-option strategies on the SPDR S&P 500 ETF Trust are seen as the most attractive hedge by Credit Suisse (SIX:CSGN) Group AG.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Evercore ISI agrees with that. The firm’s options team recommends buying SPY (NYSE:SPY) February $304 puts and selling $287 puts, strategist Dennis DeBusschere wrote in a note Tuesday, citing weakness in U.S. growth data, a slowdown in China and defensiveness showing up in VIX futures. The February expiry includes the U.S.’s advance fourth-quarter gross-domestic-product report on Jan. 30, he said.

“Since the S&P is making new all-time highs, now is an opportune time to hedge,” DeBusschere said.

(Adds VIX trading on Wednesday)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.